Kumar Brothers Chemists Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 20-12-2024
- Paid Up Capital ₹ 1.12 Cr
as on 20-12-2024
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 108.29 Cr
as on 20-12-2024
- Revenue 57.48%
(FY 2022)
- Profit -92.64%
(FY 2022)
- Ebitda -10.67%
(FY 2022)
- Net Worth 0.02%
(FY 2022)
- Total Assets -22.36%
(FY 2022)
About Kumar Brothers Chemists
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.12 Cr.
The company has closed loans amounting to ₹108.29 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashwani Kumar and Ravita Singla serve as directors at the Company.
- CIN/LLPIN
U51397CH1998PTC021377
- Company No.
021377
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kumar Brothers Chemists?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwani Kumar  | Director | 12-May-1998 | Current |
| Ravita Singla | Additional Director | 17-Jan-2024 | Current |
Financial Performance of Kumar Brothers Chemists.
Kumar Brothers Chemists Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 57.48% increase. The company also saw a substantial fall in profitability, with a 92.64% decrease in profit. The company's net worth moved up by a moderate rise of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kumar Brothers Chemists?
In 2022, Kumar Brothers Chemists had a public holding of 21.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Aug 2017 | ₹46.60 Cr | Satisfied |
Punjab National Bank Creation Date: 18 Jun 2014 | ₹2.83 M | Satisfied |
Punjab National Bank Creation Date: 18 Jun 2014 | ₹2.83 M | Satisfied |
How Many Employees Work at Kumar Brothers Chemists?
Kumar Brothers Chemists has a workforce of 3 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kumar Brothers Chemists, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kumar Brothers Chemists's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
